Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report

BACKGROUND: Metastatic colorectal cancer is one of the most common causes of cancer death worldwide. RAS and BRAF mutational analyses are strongly recommended before beginning chemotherapy in the metastatic setting for their predictive role for the efficacy of anti-EGFR monoclonal antibodies. In mos...

Descripción completa

Detalles Bibliográficos
Autores principales: De Stefano, Alfonso, Zanaletti, Nicoletta, Cassata, Antonino, Silvestro, Lucrezia, Nappi, Anna, Casaretti, Rossana, Romano, Carmela, Foschini, Francesca, Cardone, Claudia, Borrelli, Marco, Petrillo, Antonella, Budillon, Alfredo, Delrio, Paolo, Avallone, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939440/
https://www.ncbi.nlm.nih.gov/pubmed/36814823
http://dx.doi.org/10.3389/fonc.2023.1084681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939440/
https://www.ncbi.nlm.nih.gov/pubmed/36814823
http://dx.doi.org/10.3389/fonc.2023.1084681

Ejemplares similares